Log In or Register to Join The Conversation!
  • This topic is empty.
Viewing 0 reply threads
  • Author
    Posts
    • #20550

      The U.S. Food and Drug Administration approved a shorter infusion time of Ocrevus (ocrelizumab) for people with relapsing or primary progressive MS. Read the full story here.

      What are your thoughts on this news?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.
Copyright © 2017-2021 All rights reserved.

©2021 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account